Browsing by Author González Farré, Blanca

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 9 to 18 of 18 < previous 
Issue DateTitleAuthor(s)
Dec-2022HER2DX ERBB2 mRNA expression in advanced HER2- positive breast cancer treated with T-DM1Brasó Maristany, Fara; Griguolo, Gaia; Chic, Núria; Pascual, Tomás; Paré Brunet, Laia; Maues, Julia; Galván, Patricia; Dieci, Maria Vittoria; Miglietta, Federica; Giarratano, Tommaso; Martínez Sáez, Olga; Marín Aguilera, Mercedes; Schettini, Francesco; Conte, Benedetta; Angelats, Laura; Vidal Losada, Maria Jesús; Adamo, Barbara; Muñoz, Montse; Sanfeliu, Esther; González Farré, Blanca; Vivancos, Ana; Villagrasa, Patricia; Parker, Joel S.; Perou, Charles M.; Conte, Pierfranco; Prat Aparicio, Aleix; Guarneri, Valentina
28-Apr-2023HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancerOlivera Salguero, Rubén; Seguí, Elia; Cejalvo, Juan Miguel; Oliveira, Mafalda; Tolosa, Pablo; Vidal, Maria; Malumbres, Marcos; Gavilá, Joaquín; Saura, Cristina; Pernas, Sònia; López, Rafael; Margelí Vila, Mireia; Balmaña, Judith; Muñoz, Montserrat; Blancas, Isabel; Boni, Valentina; Ciruelos, Eva; Galve Calvo, Elena; Perelló, Antonia; Sánchez Bayona, Rodrigo; Cruz, Susana de la; Hoya, Miguel de la; Galván, Patricia; Sanfeliu, Esther; González Farré, Blanca; Sirenko, Valeria; Blanch Torras, Aura; Canes, Jordi; Masanas, Helena; Olmos, Rosa; Forns, Margarita; Prat Aparicio, Aleix; Casas, Ana; Pascual, Tomás
Sep-2017Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifierNavarro, Alba; Clot, Guillem; Martínez Trillos, Alejandra; Pinyol, Magda; Jares Gerboles, Pedro; González Farré, Blanca; Martínez, Daniel; Trim, Nicola; Fernàndez Pascual, Verònica; Villamor i Casas, Neus; Colomer Pujol, Dolors; Costa, Dolors; Salaverria Frigola, Itziar; Martín García, David; Erber, Wendy; López, Cristina; Jayne, Sandrine; Siebert, Reiner; Dyer, Martin J. S.; Wiestner, Adrian; Wilson, Wyndham H.; Aymerich Gregorio, Marta; López Guillermo, Armando; Sànchez, Àlex (Sànchez Pla); Campo Güerri, Elias; Matutes, Estella; Beà Bobet, Sílvia M.
8-Nov-2022Intrinsic Subtypes and Therapeutic Decision-Making in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer with Visceral Crisis: A Case ReportSchettini, Francesco; Seguí, Elia; Conte, Benedetta; Sanfeliu, Esther; González Farré, Blanca; Jares Gerboles, Pedro; Vidal i Sicart, Sergi; Ganau, Sergi; Cebrecos, Isaac; Brasó Maristany, Fara; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix; Vidal Losada, Maria Jesús
5-Mar-2020Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience.Mozas, Pablo; Nadeu, Ferran; Rivas Delgado, Alfredo; Rivero, Andrea; Garrote, Marta; Balagué Ponz, Olga; González Farré, Blanca; Veloza, Luis; Baumann, Tycho; Giné Soca, Eva; Delgado, Julio (Delgado González); Villamor i Casas, Neus; Campo Güerri, Elias; Magnano, Laura; López Guillermo, Armando
14-Jun-2016PiwiRNA-651 as marker of treatment response and survival in classical Hodgkin lymphoma.Cordeiro Santanach, Anna; Navarro Ponz, Alfons; Gaya, Anna; Díaz Beyà, Marina; González Farré, Blanca; Castellano, Joan Josep; Fuster, Dolors; Martínez, Carmen; Martínez Pozo, Antonio; Monzó Planella, Mariano
7-Jun-2019Significant Clinical Activity of Olaparib in a Somatic BRCA1-Mutated Triple-Negative Breast Cancer With Brain MetastasisPascual, Tomás; González Farré, Blanca; Teixidó, Cristina; Oleaga Zufiría, Laura; Oses, Gabriela; Ganau, Sergi; Chic, Núria; Riu Viladoms, Gisela; Adamo, Barbara; Galván, Patricia; Vidal Losada, Maria Jesús; Soy Muner, Dolors; Urbano Ispizua, Álvaro; Muñoz Mateu, Montserrat; Prat Aparicio, Aleix
7-Jun-2017Síndromes Linfoproliferativos Asociados a Inmunodeficiencias Secundarias: Papel de la Infección por Virus Herpes Oncogénicos y la Diferenciación PlasmocelularGonzález Farré, Blanca
23-Apr-2021SOLTI-1805 TOT-HER3 Study Concept: A Window-of-Opportunity Trial of Patritumab Deruxtecan, a HER3 Directed Antibody Drug Conjugate, in Patients With Early Breast CancerPascual, Tomás; Oliveira, Mafalda; Ciruelos, Eva; Bellet Ezquerra, Meritxell; Saura, Cristina; Gavilá, Joaquin; Pernas, Sònia; Muñoz Mateu, Montserrat; Vidal Losada, Maria Jesús; Margelí Vila, Mireia; Cejalvo Andújar, Juan Miguel; González Farré, Blanca; Espinosa Bravo, Martin; Cruz, Josefina; Salvador Bofill, Francisco Javier; Guerra, Juan Antonio; Luna Barrera, Ana María; Arumi de Dios, Miriam; Esker, Stephen; Fan, Pang-dian; Martínez Sáez, Olga; Villacampa, Guillermo; Paré, Laia; Ferrero Cafiero, Juan M.; Villagrasa, Patricia; Prat Aparicio, Aleix
15-Oct-2019Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cellsLópez-Guerra, Mónica; Xargay i Torrent, Sílvia; Fuentes, Patricia; Roldán, Jocabed; González Farré, Blanca; Rosich, Laia; Silkenstedt, Elisabeth; García León, María J.; Lee-Vergés, Eriong; Giménez Carabaza, Neus; Giró, Ariadna; Aymerich Gregorio, Marta; Villamor i Casas, Neus; Delgado, Julio; López Guillermo, Armando; Puente, Xose S.; Campo Güerri, Elias; Toribio, María L.; Colomer Pujol, Dolors